featured
Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase-II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS)
J. Clin. Oncol 2023 Jun 09;[EPub Ahead of Print], EN Oliva, M Riva, P Niscola, V Santini, M Breccia, V Giai, A Poloni, A Patriarca, E Crisà, I Capodanno, P Salutari, G Reda, N Cascavilla, D Ferrero, A Guarini, G Tripepi, G Iannì, E Russo, A Castelli, B Fattizzo, G Beltrami, M Bocchia, A Molteni, P Fenaux, U Germing, A Ricco, GA Palumbo, S Impera, N Di Renzo, F Rivellini, F Buccisano, A Stamatoullas-Bastard, AM Liberati, A Candoni, IM Delfino, MT Arcadi, P Cufari, L Rizzo, I Bova, MG D'Errigo, G Zini, R LatagliataFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.